Preferred Label : Somatrogon;

UNII : 6D848RA61B;

CAS number : 1663481-09-1;

NCI Metathesaurus CUI : CL553728;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/ngenla
2022
false
false
false
Netherlands
French
English
Somatrogon
Somatrogon
somatrogon
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
child
adolescent
drug approval
europe
human growth hormone
Growth Hormone Deficiency
injections, subcutaneous
growth hormone, recombinant
growth hormone, recombinant
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
somatrogon
somatrogon

---
https://www.has-sante.fr/jcms/p_3381116/fr/ngenla-somatrogon
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
somatrogon
Somatrogon
growth hormone
human growth hormone
Growth Hormone Deficiency
injections, subcutaneous
child
adolescent
continuity of patient care
somatrogon
evaluation of the transparency committee

---
https://cadth.ca/fr/somatrogon
2021
false
false
false
Canada
French
Somatrogon
drug information
failure to thrive

---
Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.